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Kashmir valley is among the known regions with highest incidence of esophageal 
cancer (EC) in the world. Life style and dietary habits together with genetic 
predisposition have been considered as the major risk factors for development of EC. 
One of the manifestations of genetic susceptibility to cancer could be an outcome of 
the differences in the capacity of xenobiotic metabolizing enzymes. The main aim of 
this study was to assess the role of risk modifying genotypes of microsomal epoxide 
hydrolase (EPHX1) (Tyr113His and His139Arg) in relation with lifestyle and dietary 
factors for esophageal squamous cell carcinoma (ESCC). Microsomal epoxide 
hydrolase is a typical detoxifying xenobiotic enzyme (mEH), with broad tissue 
distribution and substrate specificity. It is involved in the hydrolysis of potential 
genotoxic-epoxide and its intermediates (presents in diet or generated from dietary 
nitrosoamines and PAHs and environmental toxins) to corresponding less reactive 
(non-toxic) vicinal diols. In some circumstances mEH is involved in the toxification of 
its substrates, with potentially fatal outcome. Such dual role of mEH is highlighted by 
its important role in both detoxification and bioactivation of the polycyclic aromatic 
hydrocarbon benzo(a)pyrene (present in cigarette smoke). The non-synonymous 
substitutions in coding region sequence of EPHX1 mostly appear to influence 
enzymatic activity through alteration of protein stability. For example, Tyr113His 
substitution in exon 3 could reduce the enzymatic activity by about 40-50%, producing 
a slow phenotype with a low epoxide hydrolase activity. In contrast, His139Arg 
substitution in exon 4 could increase the activity by about 25%, producing a rapid 
phenotype with an increased enzymatic activity. In this case control study we analyzed 
235 histopathologically confirmed EC cases with same number of age, sex and district 
of residence matched controls for the above mentioned variants, using Polymerase 
chain reaction-Restriction fragment length polymorphism (PCR-RFLP) method. 
Conditional logistic regression models were used to calculate odds ratios (ORs) and 
95% confidence intervals (95%CIs).  
As compared to control subjects, low intake of fruits and vegetable (P = 0.001) and 
poor socioeconomic status (P = 0.003) showed a strong association with ESCC risk. 
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We also observed majority of ESCC cases (37.45%) had positive first degree family 
history of same or different cancer (P = 0.001). 
Homozygous mutant variation (His113/His113) of EPHX1 exon 3 showed an 
association with ESCC risk. As compared to the homozygous wild genotype 
(Tyr113/Tyr113), ESCC risk was increased more than 3 times for homozygous mutant 
genotype (His113/His113) (OR = 3.35; CI 1.68 – 6.29), which represent slow 
phenotype with low EPHX1 enzyme activity. In contrast, no significant association 
was found between EPHX1 exon 4 genotypes and ESCC risk (OR = 0.51; 95% CI 
0.09 – 2.76). However, when the EPHX1 exon 3 and exon 4 polymorphisms were 
considered together, the combined His113/His113 and His139/His139 genotype (exon 
3 slow allele and exon 4 slow allele) further elevated the risk of ESCC (OR = 3.93; 
95% CI 1.76 – 8.78), hence suggesting the synergistic effect of the EPHX1 exon 3 and 
exon 4 polymorphisms in increasing the risk of ESCC. On further activity based 
stratification of the genotypes the “very slow predicted activity” genotypes (resulting 
from combination of His113/His113 with His139/His139, His139/Arg139 or 
Arg139/Arg139) showed significant association with ESCC risk (OR = 2.80; 95% CI 
1.56 – 5.00).  
Elevated risk estimates were seen in smokers independently of the genotypes but the 
association was stronger among smokers with the exon 3 His113/His113 variant 
(mutant) (OR = 3.5; 95% CI 1.15-11.00). Significance of the association of predicted 
mEH activity with ESCC when stratified for smoking status was diminished (OR = 
2.29; 95% CI 0.95 – 5.53).  
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Cancer is the second leading cause of death behind heart disease and has overtaken 
heart disease as the number one cause of death in persons younger than 85 years of 
age (Jemal et al., 2011; Jemal et al., 2010). Whatever be the cause, cancer is 
characterized by - self sufficiency in growth, escape from cell cycle exit, resistance 
to apoptosis, cellular immortalization, and the ultimate acquisition of properties 
that facilitate angiogenesis, invasion and metastasis (Hanahan and Weinberg, 
2011).   
Among the more than 100 distinct types of the cancer, EC is one of the extremely 
lethal malignancy with characteristic symptoms of progressive dysphagia and 
weight loss. Currently, EC is the eight most common incident cancer in the world, 
and ranks sixth among all cancers in mortality (Ferlay et al., 2010; Kamangar et 
al., 2006). Esophageal squamous cell carcinoma (ESCC) and esophageal 
adenocarcinoma (EA) are the two main histological subtypes of EC. These cancer 
subtypes besides being histologically different also differ with respect to their 
incident trends, population that they affect and risk factors. Since 1970, incident 
rates of EA have sharply increased in some western countries, so called as “an 
emerging disease” in western population. In contrast, ESCC constitutes 90% of EC 
and continues to be the dominant type in the rest of the world (Jemal et al., 2011) 
including Kashmir (Malik et al., 2011). While the highest incidence of ESCC, is 
within the geographical region extending from central China through Iran up to 
northern India, so called “Asian esophageal cancer belt” (Islami et al., 2004), 
Kashmir valley lies to the south of this belt with reported age standardized incident 
rate of 43.6 and 27.9 per 100,000 in men and women, respectively . This incidence 
is 3-6 times higher than recorded in major metropolis cities of India and these 
figures are almost at par with the regions of world having highest incidence of EC 
(Khuroo et al., 1992).  
Owing to the complex multistep process and multi-factorial causes of EC, the exact 
etiology remains poorly understood (Bird-Lieberman and Fitzgerald, 2009; 
Kamangar et al., 2009). Recent studies have strengthened the view that food habits 
and lifestyle are closely associated with a high incidence of EC (Kamangar et al., 
2006; Khan et al., 2011; Siddiqi et al., 1992). This may be possibly due to the 
presence of potential pro/carcinogens in diet and environmental exposures 
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(Kamangar et al., 2006; Khuroo et al., 1992; Lin et al., 2009; Roth et al., 1998b; 
Siddiqi et al., 1992). Carcinogenic substances such as nitrosoamines, PAHs, 
benzene, epoxides, benzpyrene etc derived from the dietary and environmental 
exposures are in general considered as the main risk factors of EC (Kamangar et 
al., 2006). Kashmir valley has unique sociocultural and dietary features that make 
it a very intriguing region for studying this disease. People of valley are exposed to 
substantial amount of potential genotoxic carcinogens like PAH’s, epoxides, 
nitrates, N-nitroso compounds including N-nitrosopipecolic acid, mono and 
diamines of methane and ethane, with several unidentified nonvolatile N-nitroso 
compounds, aromatic amines, heterocyclic aromatic amines, mycotoxins, through 
environmental (tobacco smoking, non-vented coal pots) and peculiar dietary 
(charbroiled food-barbecued meat, home dried vegetables, pickles, fried chicken, 
deep cooked meat, salted tea-noon chai) factors (Khan et al., 2011; Mir and Dar, 
2009; Siddiqi et al., 1992). N-nitroso compounds (NOCs), polycyclic aromatic 
hydrocarbons (PAHs), heterocyclic aromatic amines (HCAs), epoxides like other 
carcinogens can act as activated carcinogens and are able to form DNA or protein 
adducts (Mirvish, 1995; Poirier, 1997; Pratt et al., 2011). DNA adduct can result 
into genetic insults in the oncogenes or gate keeper genes and can result into 
cancer development. To prevent damages to genetic material the human body has 
an inherent mechanism called as carcinogen metabolism or xenobiotic metabolism 
which is often involved in detoxification of endogenous or exogenous carcinogens, 
however in some instances intermediates produced can themselves be the cause of 
toxic effects. Individual differences to detoxify potential carcinogens explain 
difference in risk to develop the malignancy as a result of exogenous exposures. 
This different vulnerability to cancer referred as genetic susceptibility, arise due to 
different kinds of mutations in cancer related genes or could be in part due to 
sequence variations/genetic polymorphism in genes encoding products which play 
important role in the body (Gonzalez et al., 2002; Hiyama et al., 2002; Houlston 
and Tomlinson, 2001). Studies have suggested that genetic polymorphisms may 
clarify the causes and events involved in esophageal carcinogenesis (Xing et al., 
2003). More importantly the polymorphism in genes involved in metabolism & 
detoxification of carcinogens can elevate the cancer risk- through increased 
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activation of chemical carcinogens or decrease ability of cells to detoxify & repair 
mutagenic damage. 
The various observational and genetic studies from Kashmir valley are 
inconclusive and the main risk factors are yet to be identified.  These studies 
suspected the consumption of sun dried and pickled vegetables, red chilies, spiced 
cake (wur), hot salted tea and smoked fish to be the major risk factors of EC in the 
region (Chitra et al., 2004; Khuroo et al., 1992; Siddiqi et al., 1992). Moreover, 
low socioeconomic status, positive family history, and above all genetic 
susceptibility have also been implicated in the development of ESCC (Khan et al., 
2011; Malik et al., 2011). Hence we conducted a case control study with the main 
aim to understand the epidemiological risk factors as well as the genetic 
vulnerability in this high risk area of ESCC. 
Microsomal epoxide hydrolase is a major protective xenobiotic metabolizing 
enzyme (mEH) involved in general oxidative defence and in the metabolism of 
exogenous and endogenous compounds (Zusterzeel et al., 2001). The enzyme 
hydrolyzes genotoxic epoxides, yielding less reactive corresponding trans-
dihydrodiols (Oesch, 1973). Epoxides may be present in the diet or generated 
within the body from a number of sources including dietary polycyclic aromatic 
hydrocarbons and nitrosamines, environmental toxins such as carcinogenic 
benz(a)pyrene (present in cigarette smoke), benzene, and aromatic amines as 
reactive intermediates during metabolic processes (Craft et al., 1988; Oesch, 1973; 
Yang, 1988; Zhang et al., 2003). Exposures of such chemical carcinogens are 
common among the people of Kashmir (Khan et al., 2011; Khuroo et al., 1992; 
Mir and Dar, 2009; Siddiqi et al., 1992). Interspecies comparisons suggest that 
epoxide hydrolysis is a particularly well-developed bio-inactivation pathway in 
humans (Kitteringham et al., 1996), while in some instances, trans-dihydrodiols 
generated from PAHs are highly toxic and mutagenic (Oesch, 1973). An example 
is (+)-anti-7,8,9,10-tetrahydro-7,8-diol-9,10-epoxide derived from benzo(a)pyrene 
(Friedberg et al., 1994; Holder et al., 1974; Sims et al., 1974) present in the 
cigarette smoke. Therefore, mEH has a dual role in the detoxification and 
activation of procarcinogens, depending on the substrate (Oesch, 1973; Zhang et 
al., 2003). The mEH protein and nucleic acid sequence is highly conserved, and 
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the protein appears universally expressed (Kitteringham et al., 1996). Studies have 
reported that the several fold variation in substrate activity of mEH in humans is 
partly attributable to nonsynonymous genetic polymorphisms (that result in amino 
acid substitution) in exon 3 (Tyr113His) and exon 4 (His139Arg) (Hassett et al., 
1994; Ulrich et al., 2001). In vitro,  exon 3 transition mutation resulting  Tyr→His 
substitution at residue 113 (exon 3 polymorphism) is associated with a 40-50% 
decrease in the activity of mEH and mutation in exon 4 causing a His→ Arg 
substitution at residue 139 is associated with 25% increase of enzyme activity, 
probably due to altered protein stability (Hassett et al., 1994; Raaka et al., 1998). 
Given the differential effect of EPHX1 alleles in the detoxification of 
procarcinogenes, it has been proposed that these polymorphisms may affect cancer 
risk. Population based studies found that these two functional polymorphisms were 
strongly associated with susceptibility to a number of chemical carcinogen-induced 
cancers occurring in lung (Benhamou et al., 1998; Gsur et al., 2003; Park et al., 
2005; Zienolddiny et al., 2008), upper aerodigestive tract (Jourenkova-Mironova et 
al., 2000; Park et al., 2003), colorectum (Huang et al., 2005; Sachse et al., 2002), 
bladder (Srivastava et al., 2008), breast (Spurdle et al., 2007) .  
The correlation of EPHX1 polymorphism with susceptibility to esophageal cancer 
has not been reported so far from Kashmir- part of high risk “Asian esophageal 
cancer belt” and its relation in other parts of world has resulted in controversial 
results. Therefore, owing to the potential role of various genetic variations in 
modifying the risk to develop EC, the main aim of this case control study included: 
 To compare a specific set of variants of EPHX1 gene in esophageal cancer 
cases Vs controls in Kashmir. 
 To evaluate the association of such polymorphism with environmental 
factors. 
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2.1 EPIDEMIOLOGY 
Worldwide, the epidemiology of EC varies strikingly from other epithelial cancers. 
Currently, EC ranks sixth among all cancers in mortality, however it is the second 
leading cancer in terms of its ever increasing incidence (Ferlay et al., 2010; 
Kamangar et al., 2006; Parkin et al., 2005; Tomizawa and Wang, 2009). In the 
United States, an estimated 16,640 cases of EC were diagnosed in 2010, and there 
were 14,500 deaths from the disease and the prevalence is expected to increase by 
approximately 140% by 2025 (DeMeester, 2009; Jemal et al., 2011; Jemal et al., 
2010). Epidemiological studies have shown that the two main histological 
subtypes, (ESCC and EA) of extremely lethal esophageal malignancy differ vastly 
in incidence, geographic distribution, and ethnic pattern. Although the 
epidemiology of EC has changed substantially over the last 50 years, especially in 
western world, with the traditionally dominant squamous cell carcinoma being 
overtaken by adenocarcinoma, however ESCC still remains the most common 
histological subtype globally (Eslick, 2009; Jemal et al., 2011). It occurs 
frequently within a geographic region extending from the southern shore of the 
Caspian Sea on the west to northern China on the east and encompassing parts of 
Iran, Central Asia, Afghanistan, Siberia, and Mongolia- so called “Central Asian 
esophageal cancer belt” (Islami et al., 2004). The wide variation in incidence 
greater than 100- fold differences is observed between high incidence areas such as 
China and Iran, and low incidence areas as Western Africa (Ferlay et al., 2010). 
Male to female incident rate ratio also varies widely with ratios greater than 20:1 in 
France to near equality or even excess female cases in high incident areas such as 
Iran (Day, 1975; Kmet and Mahboubi, 1972). Globally, a higher incidence of EC is 
seen in men with average 3-4 fold increased rate for ESCC and a 7-10 fold 
increased rate for EA compared to women (Vizcaino et al., 2002). The North 
Indian “Kashmir valley” that borders the southern “Asian esophageal cancer” belt 
is another high risk region, which exhibits variation in incidence over a short 
distance of 150 km. A prospective study between 1986 and 1989 reported ASR of 
70 per 100,000 men in Islamabad and 17 per 100,000 men in Kupwara (Khuroo et 
al., 1992). In Kashmir Valley, EC constitutes more than 20% of all cancer (Dhar et 
al., 1993; Mattoo and Kaul, 1974) with ESCC being the most common subtype of 
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EC (Malik et al., 2011). Despite of high incident rates of EC, there has been no 
advance in data collection and surveillance statistics, not to mention the 
development of cancer registries to collect prevalence data from this part of the 
world.  
2.2 ETIOLOGY  
Esophageal carcinogenesis is a complex multi-step process carrying multi-factorial 
etiology. The marked difference in the epidemiological studies has strongly 
implicated dietary and environmental factors along with a contribution from 
genetic predisposition in development of ESCC (Souza, 2002). Although number 
of factors has been attributed to increase the risk of ESCC, yet exact etiology of the 
disease is unknown and individual biomarker for ESCC has not been identified so 
far. Carcinogen (Direct acting carcinogens or Procarcinogens) exposure from diet 
and environment result in series of somatic mutations or epigenetic changes or 
chronic inflammation. Many such mutations confer survival benefits on mutated 
cells and lead to clonal expansion at the expense of the other cells thus leading to 
the development of ESCC. Changes in ESCC frequency among geographically 
distinct populations, high ESCC rates associated with specific dietary factors, and 
high risk of smoking-associated ESCC suggests that dietary and lifestyle exposures 
are major determinants of ESCC risk, although genetics plays an indispensable role 
in ESCC risk. Besides that low socioeconomic status, consumption of hot salted 
tea, nutritional deficiencies are other precipitating factors in ESCC. To date, in 
Kashmir valley no single factor has been identified as the main cause of the high 
incidence of ESCC as compared to other regions of India. Studies have shown that 
the three main components- a societal component with poor, rural lifestyle and 
general deprivation, status in particular in vitamins and oligoelements; a life style 
component with the use of copper utensil in cooking, the consumption of spicy, 
deep fried food stuffs, and drinking of hot salted tea; and an environmental 
component with exposure to high levels of dietary nitrosoamines, PAH’s from 
diverse sources, can emerge as important factors for understanding the etiology of 
the disease in this part of world in particular and other high risk regions of the 
world in general by carrying  out comparative studies (Mir and Dar, 2009). 
Further, number of observational studies has attributed the high risk of ESCC in 
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Kashmir to unique dietary and lifestyle habits, which however lack concrete 
scientific substantiation.      
2.2.1. Environmental and dietary causes of ESCC 
Large number of factors has been investigated in relation with ESCC; many of 
them either have been scientifically established or possess substantial data. 
Cigarette smoking is a known risk factor for ESCC. There exists a causal 
relationship between the cigarette smoking and development of ESCC (IARC 
working group, 2012). This causal relationship is supported by the fact that 
smoking causes cancers of other organs (Danaei et al., 2005) and further by the 
presence of a large number of carcinogens, such as PAH’s, nitrosoamines, and 
acetaldehyde in tobacco smoke (Hecht, 2003). Several studies have confirmed that 
ESCC risk is increased approximately 3 fold-7 fold in current smokers (Carstensen 
et al., 1987; Doll et al., 1994; Freedman et al., 2007a; Ishikawa et al., 2006; 
McLaughlin et al., 1995) and smoking cigars or pipe confers risk similar to 
cigarette smoking. In addition, IARC (The International Agency for Research on 
Cancer) has concluded that chewing betel quid that includes tobacco, common 
among the people of South and South-East Asia, can also cause ESCC (Humans, 
2004). Other forms of tobacco use, such as using water pipe (hookah) and chewing 
nass (a mixture of lime ash and tobacco) are predominant in the Eastern 
Mediterranean region, some parts of Asia, including India, and North Africa. 
Studies have reported increasing trend of hookah smoking among young people in 
these regions and also in several countries in Europe and North America (Jackson 
and Aveyard, 2008; Jawaid et al., 2008; Jordan and Delnevo, 2010; Maziak, 2011; 
Smith et al., 2011). Hookah smoke consist of many toxic components such as 
nicotine, nitric oxide, carbon monoxide, PAH’s and nitrosoamines (Eissenberg and 
Shihadeh, 2009; Ghasemi et al., 2010; Jacob et al., 2011; Monzer et al., 2008). 
Moreover, hookah smokers may be exposed to harmful smoke from burning 
charcoal (Monzer et al., 2008) and exposure to smoke per puff with hookah 
smoking may be even higher than with cigarette smoking (Eissenberg and 
Shihadeh, 2009). Kashmir valley, northernmost part of India, considered as the 
moderate to high incidence area for esophageal cancer, the prevalence of hookah 
smoking and nass chewing is relatively high, suggesting that these habits might be 
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important risk factors for ESCC in the valley (Mir and Dar, 2009; Siddiqi and 
Preussmann, 1989). A recent case control study from the valley revealed 
association of hookah smoking and nass chewing with approximately two- and 
three-fold increase, respectively, in the risk of ESCC whereas study also showed 
no association between cigarette smoking with the ESCC risk (Dar et al., 2012), 
indicating that the high rate of ESCC in Kashmir cannot be attributed to smoking 
exclusively. Other environmental and genetic factors may be contributing in the 
pathogenesis of ESCC in this area. Alcohol drinking (three or more drinks per day) 
has almost universally been known to be major cause of ESCC. It typically 
increases risk by 3-5 folds (Boffetta and Garfinkel, 1990; Brown et al., 2001; 
Brown et al., 1994; Freedman et al., 2007a). Although the exact mechanism of 
carcinogenicity is not known, but several mechanisms for its carcinogenicity have 
been suggested including its conversion to acetaldehyde, acting as solvent for other 
carcinogens, and causing nutritional deficiency (Boffetta and Hashibe, 2006). In 
Kashmir, unlike other high ESCC incident areas, drinking alcohol is almost 
negligible, due to the religious belief of the people of valley (Khuroo et al., 1992; 
Mir and Dar, 2009). In a recent hospital based case control study in the valley, only 
1.1% of ESCC cases had ever drunk alcohol whereas none of the controls was an 
ever drinker (Dar et al., 2012). Further, suggesting the role of other risk factors in 
the development of ESCC, in the valley. 
Number of chemicals has been found to be carcinogenic in animal studies, and 
have been related with the development of ESCC. Studies have shown positive 
association between the polycyclic aromatic hydrocarbons- chemical carcinogen 
with the risk of developing ESCC in Linxain (Roth et al., 1998a; Roth et al., 
1998b) and Golestan Province of Iran (Kamangar et al., 2005; Pourshams et al., 
2010), although the association is based on ecological studies and therefore is 
circumstantial. The major source of exposure to PAH’s are smoking tobacco 
(Danaei et al., 2005), eating charbroiled meat, deep fried meat and chicken, and 
other food products (Kazerouni et al., 2001), air pollution (Chang et al., 2006), and 
occupational exposures (Mastrangelo et al., 1996). Pertinently, people of Kashmir, 
have been found to be exposed to PAH’s through specific habits (whether it be the 
use of tobacco via cigarette smoking, tobacco chewing, use of traditional Hookah 
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smoking, or through burning of coal in so called traditional Kangri) or unique 
dietary habits (like charbroiled and deep cooked meat) prevailing in the valley and 
their association with ESCC has been reported by several studies (Lunn et al., 
2007; Siddiqi et al., 1991; Wu et al., 1993). N-nitroso compounds (NNCs) are 
another group of compounds demonstrated to be carcinogenic for esophageal 
cancer and cancer of nasal cavity, stomach in animal studies (Fong et al., 1997; 
Ivankovic et al., 1998; Lijinsky and Kovatch, 1985; Preussmann et al., 1983). 
Humans are exposed to NNCs from tobacco smoking, occupational exposures, and 
many food sources (Bartsch and Spiegelhalder, 1996) and also from endogenous 
synthesis which contributes to 45% to 75% of the total exposure (Tricker, 1997). 
Nitrosamines and nitrosamides, two major subgroups of NNCs, are formed by the 
endogenous reaction of nitrites with amines or amides, respectively. Nitrites are 
directly found in sodium nitrite and various foods, and are also formed by 
reduction of ingested or salivary nitrates (Forman, 1987; Mirvish, 1995). 
Vegetables are the main sources of exogenous nitrates but high levels of nitrates 
may also be found in water (Mirvish, 1983). Reduction of nitrates to nitrites by 
oral bacteria is a major contributor to the formation of NCCs and may be one of 
the reasons why poor oral health has been associated with higher risk of ESCC and 
gastric cancer (Abnet et al., 2005a; Abnet et al., 2001). Further, case control and 
cohort studies associated nitrosoamine exposure and foods (processed meat- a 
major source of nitrites and nitrosamines) that are direct or indirect sources of 
these compounds with ESCC risk (Jakszyn and Gonzalez, 2006).  Nevertheless, the 
analytical studies of Kashmiri foods indicate the possibility of substantial exposure 
to N- nitroso compounds (N- nitrosopipecolic acid, mono-nitrosopiperazine, 
methyl benzylnitrosoamine, diethylnitrosoamine, and dimethynitrosoamine) from 
dietary items like salt tea, dried fish, sun dried vegetables, vegetables especially 
Brassica olerecea (haak), red chillies, spice cake (wur), thus may predispose the 
people of valley to ESCC risk (Siddiqi et al., 1992; Siddiqi and Preussmann, 1989; 
Siddiqi et al., 1988b; Siddiqi et al., 1991). 
Direct as well as indirect mechanisms have been proposed by which thermal injury 
may contribute to increased ESCC risk. Thermal injury most often induces chronic 
inflammation which may stimulate endogenous formation of reactive nitrogen 
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species and impaired barrier function which may increase the risk of damage by 
intra-luminal carcinogens. Several studies have related hot beverage consumption 
to increased risk of ESCC in South America, Japan, Singapore, and high risk 
regions of Golestan, Iran (Castellsague et al., 2000; De Jong et al., 1974; 
Ghadirian, 1987; Pintos et al., 1994; Segi, 1975). The study carried out in the high 
risk regions of Golestan, Iran showed the risk of ESCC not only associated with 
the consumption of hot black tea as compared to lukewarm black tea but also 
increased risk associated with drinking tea immediately after pouring than drinking 
after more than four minutes after pouring (Islami et al., 2009b). On the other 
hand, studies have related increased EC risk with the chemical constituents of the 
beverages rather than the beverage temperature alone. Mate, a herbal tea consumed 
in South America, which may increase the risk of EC even at low temperatures 
have been proposed to contain known carcinogens- PAH’s (Castellsague et al., 
2000; Fagundes et al., 2006; Sewram et al., 2003). In addition, studies carried out 
in Kashmir have also associated the traditional consumption of hot salted tea with 
increased risk of ESCC in valley (Malik et al., 2010; Phukan et al., 2001; Sharp et 
al., 2001). The hot salted tea does more than thermal injury to esophagus 
epithelium, as the method of preparation involves boiling the tea leaves for longer 
periods (usually more than an hour) with further additions of sodium bicarbonate 
and common salt (NaCl). This method of preparation has been reported to result in 
the formation of mono and di nitrosamine caffeidines- the suspected carcinogens, 
in addition of high amounts of N- nitrosopipe-colic acid and several unidentified 
non-volatile N-nitroso compounds on nitrosation of tea extracts (Siddiqi et al., 
1988a; Siddiqi et al., 1991). Further, common salt is a well known gastric 
epithelium irritant and has been considered as a risk factor for gastric cancer 
(Correa, 1987).  
Several ecological studies have shown higher risk of EC in areas that used higher 
amounts of pickled vegetables (Yang, 1980). However, the results of 
epidemiological studies and case control studies have been inconsistent. Some case 
control studies have shown an association of pickled vegetable intake with 2 fold 
to 3 fold increased risk of EC (Hung et al., 2004; Wang et al., 2006; Yang et al., 
2005), yet others have shown no association (Hu et al., 1994; Tran et al., 2005).  
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IARC in 1993 concluded that traditional Asian pickled vegetables are possibly 
carcinogenic to humans (Group 2B), which is further supported by the  studies 
carried out in Kashmir, suggesting the association of pickled vegetable intake 
(containing N-nitroso compounds) with increased incidence of ESCC in the valley 
(Mir and Dar, 2009). Studies have revealed pickled vegetables are mutagenic on 
Ames test (Cheng et al., 1980; Lu et al., 1981; Yang, 1980), and have also 
suggested the growth of fungi and yeasts in pickled vegetables may release many 
potential carcinogenic compounds such as N- nitrosoamines, Roussin red methyl 
ester and mycotoxins (Cheng et al., 1981; Yang, 1980; Zhang et al., 1983).   
EC has long been considered as the disease of poor and the socially disadvantaged. 
Several epidemiological studies have confirmed an inverse relation between the 
socio economic status and esophageal cancer (Bosetti et al., 2001; Jansson et al., 
2005; Nagel et al., 2007; Tran et al., 2005; Wei et al., 2005; Weiderpass and 
Pukkala, 2006), by taking into account different SES indicators like income, 
education etc. SES itself neither is a well defined entity nor is the direct biological 
cause of EC. Although SES is a unifying marker for the set of prevailing factors 
like poor nutritional status, low intake of fruits and vegetables, occupation and 
lifestyle (Islami et al., 2009a; Shavers, 2007) which contribute to the risk of EC. 
Low intake of fresh fruits and vegetables has been considered by several studies as 
a possible risk factor for EC (Freedman et al., 2007b; Gonzalez et al., 2006; 
Yamaji et al., 2008; Yang et al., 2005), and it is further inferred that high intake of 
fruits and vegetables probably decrease EC risk by approximately 20% per 50g of 
fruit or vegetable intake per day (Thompson, 2010). Evidence from several studies 
has suggested the important role of vitamin and micronutrient deficiency in the 
etiology of ESCC and several other cancers. Further in vitro studies had shown that 
the antioxidant effect of some vitamins could prevent tumor formation and people 
in high risk ESCC areas had severe deficiencies in some vitamins and minerals 
(Yang et al., 1984). Both observational and experimental studies have shown 
higher selenium status reduces the risk of esophageal and gastric cancers in 
selenium deficient populations (Li et al., 1993; Mark et al., 2000; Wei et al., 
2004). Yet another study has revealed significant dose response relationship 
between lower levels of Zinc and increased risk of ESCC (Abnet et al., 2005b). 
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Zinc deficiency has been shown to enhance the effects of N-
nitrosomethylbenzylamine and certain other nitrososamines in esopahgeal 
carcinogenesis in rodents (Fong et al., 1997; Fong and Magee, 1999). 
2.2.2 Genetic factors 
Genetic susceptibility and Gene Environment Interaction  
A rich and complex body of research has revealed cancer to be a disease involving 
dynamic changes in the genome, based on the foundation of mutations that produce 
oncogenes with dominant gain of function and tumor suppressor genes with 
recessive loss of function (Hanahan and Weinberg, 2011; Nishihira et al., 1993). 
Although epidemiological evidences implicated the role of environmental and 
dietary factors in ESCC risk, yet only a subset of individuals exposed to the same 
type and dose of carcinogen will develop ESCC, further explaining the 
indispensable role of genetic alterations in esophageal carcinogenesis. Moreover, 
alterations in certain key genes (proto oncogenes and tumor suppressor genes) have 
already been linked to elevated risks of developing various cancers, including 
malignancies of the esophagus (Cai et al., 2005; Lee et al., 2000; Mir et al., 2007; 
Mir et al., 2005). Although a number of genetic abnormalities have been associated 
with ESCC, varying between high risk populations however till now no single 
gene has been identified as pivotal in the pathogenesis of ESCC.  
The genetic alterations that contribute to pathogenesis of cancer are either tumor 
specific (somatic) or inherited (that arise from germ line mutations in a cancer 
susceptibility gene) (Garber and Offit, 2005). Inherited genetic factors, in 
conjunction with their interaction with other clinical variables (tobacco and alcohol 
exposure, exposure to various chemical carcinogens from environment and diet, 
and low intake of nutrients in case of ESCC), can alter the efficacy of the various 
intracellular pathways that ultimately result in carcinogenesis (Pelucchi et al., 
2008; Yousef et al., 2008). In addition to various established clinical risk factors 
for ESCC, such as alcohol, smoking, chemical carcinogens, and micronutrient 
deficiency, familial aggregation of esophageal cancer have frequently been 
described (Hu et al., 2003; Ji and Hemminki, 2006). Likewise, those with a family 
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history of esophageal cancer have an increased risk of the disease (Akbari et al., 
2006). Whether these patterns simply reflect common environmental exposures 
among family members or actual inherited predisposition is uncertain, but pattern 
suggests that the genetic factors significantly contribute to esophageal 
tumoriogenesis. This interplay between the genes and these clinical variables is 
referred to as gene-environmental interactions (Edwards and Myers, 2008; Taioli, 
2008). Thus the genes and the other key factors affecting genetic susceptibility 
represent the foundation of the emerging field of molecular epidemiological 
research. Presently, there is a mounting interest in clarifying the role played by 
genetic factors in cancer susceptibility.  
With the sequencing of the human genome, it is evident that about 99% of the 
DNA is identical in every human genome (Lander et al., 2001; Marth et al., 2001; 
Venter et al., 2001) and the 0.1% difference is responsible for the inter-individual 
variation and the unique phenotype of each individual. Among these minor genetic 
variations are single base changes in genome, called as Single nucleotide 
polymorphism (SNPs). Studies have revealed SNPs play important role in 
promoting susceptibility to diseases as well as the response of the individual to 
various drugs and environment/carcinogens (Hemminki and Shields, 2002). 
Discovering the DNA sequence variants that contribute to common disease risk 
offers one of the best opportunities for understanding the complex causes of 
disease in humans (Ryk et al., 2006). Therefore, genetic polymorphism may act as 
molecular markers that can provide important predictive and prognostic 
information about cancer and studies of interaction between environment and 
genes may have great potential for exploring mechanisms, identifying susceptible 
population/individuals and making practical use of study results to develop 
preventive strategies beneficial to human health.  
The genes grouped as primary candidate and have a major role to play in 
carcinogenesis serving as markers for predicting cancer risk are the probable 
cancer susceptibility genes. As the primary event due to carcinogen exposure is 
DNA damage which has to be safeguarded. The number of genes are responsible 
for carrying out this function and thereby preventing cancer. There are two sets of 
enzymes which fall in this category – (i) enzymes that detoxify endogenous and 
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exogenous carcinogens called xenobiotic metabolizing enzymes or, (ii) repair 
enzymes that repair the damage in the DNA from the carcinogens. If the damaged 
DNA is not efficiently repaired, the ‘gate-keeper genes’ which directly regulate 
growth and differentiation pathways of the cell and comprise of oncogenes and 
tumour-suppressor genes, either stop the cell from proliferating further in order to 
repair the damaged DNA once again, or eliminate the cell via programmed cell 
death (apoptosis). If the cell with damaged DNA continues to proliferate, 
accumulation of further genetic lesions may result in malignant transformation 
(Figure 1). So the primary candidates of cancer susceptibility are those genes that 
are involved in carcinogen metabolism, repair of DNA damage and control of cell 
signalling and cell cycle.  
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Figure 1 General scheme of the events occurring during the metabolism of 
xenobiotics. 
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2.3 GENERAL DESCRIPTION OF MICROSOMAL EPOXIDE 
HYDROLASE (EPHX1) 
Epoxide hydrolases (EC 3.3.2.7-11) are typical detoxifying enzymes catalyzing the 
hydrolysis of electrophilic and therefore potentially genotoxic–epoxides to the 
corresponding less reactive vicinal diols. The best example is mammalian 
microsomal epoxide hydrolase (mEH) encoded by the EPHX1 gene, an enzyme 
capable of inactivating a large number of structurally different, highly reactive 
epoxides and therefore is an important part of the enzymatic defense against 
adverse effects of foreign compounds (Decker et al., 2009; Zusterzeel et al., 2001). 
Epoxides may be present in the diet or generated within the body from a number of 
sources including dietary polycyclic aromatic hydrocarbons and nitrosamines, 
environmental toxins such as carcinogenic nitrosamines, benz(a)pyrene (present in 
cigarette smoke), benzene, and aromatic amines as reactive intermediates during 
metabolic processes (Craft et al., 1988; Gonzalez et al., 1982; Jerina, 1983; Yang, 
1988). Epoxides often show electrophilic reactivity leading to their genotoxic 
potential. The hydrolysis of epoxide by mEH results in increased water solubility 
of the metabolites and termination of its genotoxic potential. Thus mEH classically 
plays a major detoxification role in xenobiotic metabolism due to its exceptionally 
broad substrate selectivity and prominent expression in the upper aerodigestive 
tract, gonads, kidneys, lungs, liver, brain prostate, intestine, heart and bronchial 
epithelial cells (Coller et al., 2001; Janot et al., 1993; Omiecinski et al., 1993; 
Seidegard and DePierre, 1983; Wang et al., 1982) ensuring widespread defence 
against potential genotoxic epoxides (Hassett et al., 1994). Under some 
circumstances the mEH is involved in the toxification of its substrates, with 
potentially fatal outcome. Such dual role of mEH is highlighted by its important 
role in both detoxification and bioactivation of the polycyclic aromatic 
hydrocarbon benzo(a)pyrene (Shou et al., 1996). While enzyme can detoxify many 
CYP derived epoxides, in particular dihydrodiol epoxide of polycyclic aromatic 
hydrocarbon benzo(a)pyrene, benzo(a)pyrene-7,8,9,10-tetrahydro-7,8-diol-9,10-
epoxide, is not a substrate for mEH and consequently displays a highly genotoxic 
potential (Friedberg et al., 1994; Holder et al., 1974). Therefore mEH has a dual 
role in the detoxification and activation of procarcinogenes (Oesch, 1973; 
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Omiecinski et al., 1994; Zhang et al., 2003), and its role in carcinogenesis depend 
on the formation rate of reactive epoxide intermediates and elimination capacity of 
the mEH. If the formation rate of epoxide intermediate exceeds the elimination 
capacity of the mEH, its steady state level is escaping the control of the enzyme, 
representing the mechanistic basis of a practical threshold for chemical 
carcinogenesis by the compounds that are detoxified by mEH (Oesch et al., 2000).  
The human EPHX1 gene is located on the long arm of chromosome 1 (1q 42.1) 
and is approximately 20kb in size, composed of eight introns and nine exons, of 
which exon 2-9 are coding (Falany et al., 1987).  The structure and the location of 
the EPHX1 on human chromosome is shown in Figure 2. To date, more than 110 
single nucleotide polymorphisms (SNPs) have been identified in EPHX1 according 
to the NCBI's dbSNP database. Two prominent non synonymous SNPs among 
them, Tyr113His (rs1051740, in exon 3) and His139Arg (rs2234922, in exon 4), 
have been well characterized both in vitro studies and epidemiological 
investigation (Hassett et al., 1994; Omiecinski et al., 2000; Ulrich et al., 2001). 
The reported SNPs in EPHX1 are summarized in Table 1. The protein variants 
resulting from the different haplotypes have been reported to display different half 
lives, so that these genetic variants may have impact on mEH activity in vivo 
(Hassett et al., 1994; Hassett et al., 1997). In exon 3, a T to C transition mutation 
resulting in Tyr→His substitution at residue 113 (exon 3 polymorphism) is 
associated with a 40-50% decrease in the activity of mEH. This allelic conversion 
has been referred to as “slow” allele. The second variant is characterized by the A 
to G transition mutation in exon 4 causing a His→ Arg substitution at residue 139 
and a 25% increase of enzyme activity. This allele has been called the “rapid” 
allele (Hassett et al., 1994). It is suggested amino acid substitution may result in 
the altered stability of mEH protein and hence altered enzymatic activities (Hassett 
et al., 1994; Raaka et al., 1998). When both mutations are present, mEH activity 
approximately equals normal (Hassett et al., 1994). Four levels of predicted mEH 
activity (very slow, slow, intermediate, and rapid) were assigned according to in 
vitro expression of the variant alleles (Benhamou et al., 1998; Smith and Harrison, 
1997).  
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Figure 2: Structure of human chromosome number 1 showing location of EPHX1 
gene (Source www.ncbi.net). 
 
 
                                                                                                                             
Table 1: Showing SNPs in EPHXI gene 
 
Polymorphism 
               
NCBI SNP ID 
         
Chromosome 
location 
       
Mutational 
transition 
             
Amino acid 
change 
EPHX1    
Exon 3 
rs1051740 1q 42.1 T→C Tyr→His 
EPHX1    
Exon 4 
rs2234922 1q 42.1 A→G His→Arg 
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mEH polymorphisms may lead to differences in detoxification and bioactivation of 
procarcinogens, resulting in altered susceptibilities to cancers of various tissues 
(Lin et al., 2007; Mittal and Srivastava, 2007; Srivastava et al., 2004; Tranah et al., 
2005). The relationship between mEH gene polymorphisms and susceptibility to 
cancer studied had inconsistent conclusions due to different cancer types and 
populations. EPHX1 polymorphism has been associated with chemical carcinogen-
induced cancers occurring in lung (Lee et al., 2002; Zhou et al., 2001), ovary 
(Lancaster et al., 1996), colorectum (Harrison et al., 1999), and liver (Tiemersma 
et al., 2001). The Tyr allele in exon 3 was reported to increase the risk of several 
cancer types including ovarian cancer (Lancaster et al., 1996), oropharyngeal 
cancer (Amador et al., 2002), and acute leukaemia (Lebailly et al., 2002), whereas 
His allele was associated with increased susceptibilities to cancers occurring in 
colon (Harrison et al., 1999), liver (Tiemersma et al., 2001) and cervix (Sierra-
Torres et al., 2003). Studies associating mEH polymorphism with esophageal 
cancer have obtained apparently contradictory results (Jain et al., 2008; Zhang et 
al., 2003). The correlation of EPHX1 polymorphism with susceptibility to EC in 
population of Kashmir has not been reported so far. Therefore, the current study 
investigated the mEH variants in ESCC patients and controls from Kashmir.                                                                                                                 
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3.1. STUDY SUBJECTS 
The study was a hospital based case control type undertaken to investigate the 
possible association of microsomal epoxide hydrolase (EPHX1) variants with 
susceptibility to esophageal cancer in a population of Kashmir. The study was 
approved by the Ethical committee of the Sher-i-Kashmir Institute of Medical 
Sciences (SKIMS).   
This study evaluated 235 patients with histopathologically and endoscopically 
confirmed esophageal carcinoma. The cases were recruited from the out patient 
department (OPD) section of Regional Cancer Centre (RCC) of the Oncology 
department of SKIMS and equal number of controls were taken from various in-
patient wards of the SKIMS viz Cardiology, General Medicine, General Surgery 
and Nephrology Department. Informed consent was obtained from all the recruited 
subjects. Information regarding sex, age, smoking habits, and family history was 
taken through well structured questionnaires from all subjects. Blood sample was 
also obtained from every subject.  
3.1.1. Cases 
All the esophageal cancer patients that visited the OPD section of Oncology 
department of SKIMS during the study period were included as cases irrespective 
of their gender and stage of the cancer. 
Inclusion criteria 
The diagnosis of esophageal cancer was based on the standard histopathological 
criteria. The criteria’s for including a subject as case in the study were: 
 Histopathologically and endoscopically proven esophageal cancer case. 
 Patients who were willing to participate in the study. 
 Patients belonging to Kashmir region. 
Exclusion Criteria 
Under the following conditions the patients were not recruited in the study: 
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 EC patients suffering from any other malignancy also.  
 Patients who had received prior chemo or radiotherapy for EC. 
 Patients who were less than 18 years of age. 
 Patients who refused to participate. 
3.1.2. Controls 
Controls were matched to the cases by age ( 5yrs), gender and region and were 
recruited from the different in-patient wards of SKIMS. 
Inclusion criteria 
 Patients asymptomatic for esophageal cancer. 
 Patients without a history of cancer and non malignant conditions like 
corrosive esophageal injury, achalasia, barrett’s esophagus (BE) or 
gastroesophageal reflux disease (GERD). 
 Residents of the Kashmir region. 
Exclusion criteria  
 Patients who suffered from any kind of malignancy. 
 Patients suffering from disease that affected their life style and dietary 
habits like diabetes. 
3.2. QUESTIONNAIRE FOR EPIDEMIOLOGICAL STUDY 
All the cases and controls included in the study were first asked for their 
willingness to participate in the study through a written consent. A highly 
structured and well drafted questionnaire was used to collect information from the 
subjects about the demographic profile, life style, family history and other 
important aspects related to study. The interview of the controls was taken at their 
respective wards and of the cases in the OPD section of Department of Oncology, 
SKIMS. The questionnaire (Appendix) designed for the study collected information 
on: 
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 Socio-demographic characteristics including age, education, ethnicity, 
urban/rural status etc. 
 Life style habits like tobacco smoking and alcohol drinking. 
 Personal medical history and family history of disease. 
 Exposure to any kind of radiation. 
 Medical history of the participant. 
3.3. COLLECTION OF BLOOD SAMPLES 
Blood samples were collected from all 470 study subjects. Five millilitres of the 
venous blood was obtained through vein puncture in an EDTA coated (0.5M, pH-
8.0) sterilized plastic vials and stored at -80
o
C for future use. The vials were 
properly labelled according to a specially designed coding system. This coding 
system was developed so as to prevent possible mixing of the sample vials and for 
easy retrieval of the required blood sample vial. 
3.4. GENETIC ANALYSIS 
3.4.1. Extraction of genomic DNA 
Genomic DNA was isolated from blood leukocytes by standard phenol-chloroform 
method (Sambrook and Russel, edition, 2001). Blood samples (each 5ml) were 
thawed and cells were lysed with freshly prepared lysis solution (15ml) (155mM 
NH4Cl2, 10mM KHCO3 and 0.1mM EDTA), shaken for 2-3 min and then kept at -
20
o
C for 30 min. The lysed cell suspension was centrifuged at 4000 rpm for 10 min 
at 4
o
C. Pellet was re-suspended in 5 ml of SE solution, 10µl of 100ng/µl 
proteinase-K and 1 ml of 10% SDS, followed by incubation at 37
o
C for overnight. 
Next day 5ml of equilibrated phenol was added with proper mixing by inverting 
the tube for 15-30 minutes. This was followed by centrifugation at 6000 rpm for 10 
min and the aqueous layer so obtained was retained in a new tube. To this aqueous 
layer, 2.5ml of phenol and 2.5 ml of chloroform-isoamyl alcohol (24:1) was added 
and shaken gently for 10 minutes and then again centrifuged at 6000 rpm for 10 
minutes at 4
o
C. Again the aqueous layer was collected and to it 5ml of chloroform-
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isoamylalcohol was added and shaken gently for 10 minutes. The tubes were 
centrifuged at 6000 rpm for 10 minutes at 4
o
C. The aqueous layer was transferred 
to a fresh tube and to it was added 0.5 ml of chilled sodium acetate (pH 5.2) and 3 
ml of chilled isopropanol. The precipitated DNA was washed with 70% ethanol. 
The DNA was retrieved, dried and dissolved in 500 µl of 10 mM Tris (pH 8). 
3.4.2. Qualitative and quantitative analysis of genomic DNA  
Qualitative Analysis 
The integrity of the genomic DNA was examined by gel electrophoresis using 
0.7% agarose gel. Each DNA sample (2 µl) was mixed with 1µl of 1X DNA 
loading dye (1X loading dye consists of 4.16 mg bromophenol blue, 4.16 mg 
xylene cyanol and 0.66g sucrose in 1ml water) and was loaded into the well. 
Electric current was applied at 20 volt until DNA entered in to the gel and was 
raised to 50 volt for rest of the run. Run was stopped when the dye had travelled 
nearly 2/3rd of the gel. DNA in the gel needs to be stained and visualized and the 
reagent used for this purpose was the fluorescent dye “ethidium bromide”. 
Electrophoresis was performed with ethidium bromide incorporated into the gel. 
Gel was visualized by a Gel doc system (Alphaimager TM 2200, Alpha Innotech 
Corporation) under UV light and picture was captured by using CCD camera 
system.  
The integrity of the genomic DNA isolated from the blood samples was checked 
on 0.8% agarose gel. The representative gel picture of the isolated genomic DNA 
is given in the Figure 2.  
Quantitative Analysis 
The quantity of the DNA was determined by measuring optical density (OD) at 
260nm and 280 nm by double beam spectrophotometer (Spectron 2206) and the 
concentration was determined by using the fact that 1 absorbance unit equates to 
50 µg/cm
3
. Therefore, the concentration of DNA sample is given by the following 
equation 
DNA (µg/ml) = A260 x 50 x dilution factor 
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The ratio of 260/280nm was calculated to check the purity of DNA. The DNA 
samples for which the ratio was in the range of 1.7-1.9 were considered for the 
future use. The DNA was stored at 4
o
C for a short time but the vials were kept at -
20
o
C for longer duration storage. 
 
 
Figure 3 Representative gel picture showing the integrity of the genomic DNA on 
0.8% agarose. Lane 1 to 6 contains the genomic DNA isolated from the EC cases. 
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3.5. EPHX1 GENOTYPING BY PCR AND RFLP ANALYSIS 
Two separate polymerse chain reactions (PCRs) were used to detect the two 
mutations in the EPHX1 gene, namely Tyr131His in exon 3 and His139Arg in 
exon 4.  
3.5.1. Identification of the EPHX1 Tyr113His variant (exon 3 polymorphism) 
The exon 3 T to C variant in EPHX1, changing tyrosine 113 to histidine, was 
analysed by polymerase chain reaction and subsequent RFLP assay. PCR was 
performed in a 25µl reaction volume containing 100ng of DNA template, 10mM 
Tris-HCl (pH = 8.3), 50mM KCl, 1.5mM MgCl2, 0.3mM deoxyribonucleotide 
triphosphates (Irani), 20 pmol of each oligonucleotide (sense and antisense) and 
1.25U of Taq polymerase (Fermentas, Vilnius, Lithuania). EPHX1 exon 3 locus 
amplification was achieved using oligonucleotides described in Table 2.   
Amplification was achieved using a Thermal cycler (Biometra, T Professional). 
The PCR profile consisted of an initial denaturation step at 95°C for 5 minutes, 
followed by 32 cycles with denaturation steps at 95°C for 1 minute, primer 
annealing at 56.3°C for 45 seconds, and primer extension at 72°C for 1 minute. 
The PCR program was completed by final extension step at 72°C for 10 minutes to 
allow the complete extension of all PCR fragments. The PCR product exhibited a 
162 base-pair fragment and was checked on 2.5% agarose gel.   
PCR product (10 µl) was digested overnight with 10U EcoRV (Fermentas), and 
visualized by electrophoresis on 3% agarose containing 0.5 mg/mL ethidium 
bromide. The downstream primer abuts directly onto the mutation site and 
produces an EcoRV restriction enzyme site (GATATC) in the wild type only. The 
homozygous wild type (Tyr113/Tyr113) resulted in two bands (140 and 22 bp), 
heterozygous individuals (Tyr113/His113) had three bands, and homozygous 
variant type (His113/His113) had a single band of 162 bp. The EPHX1 exon 3 
polymorphism was visualized by a Gel doc system (Alphaimager TM 2200, Alpha 
Innotech Corporation) under UV light and picture was captured by using CCD 
camera system. 
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3.5.2. Identification of the EPHX1 His139Arg variant (exon 4 polymorphism) 
The exon 4 (A→G) polymorphic site changing histidine 139 to arginine was 
analyzed by PCR-RFLP method. PCR reaction was carried out in a 25 µl reaction 
volume containing 100ng of DNA template, 10mM Tris-HCl (pH = 8.3), 50mM 
KCl, 1.5mM MgCl2, 0.3mM deoxyribonucleotide triphosphates (Irani), 20 pmol of 
each oligonucleotide (sense and antisense) and 1.25U of Taq polymerase 
(Fermentas, Vilnius, Lithuania). EPHX1 exon 4 locus amplification was achieved 
using oligonucleotides described in Table 2.   
Amplification was achieved using a Thermal cycler (Biometra, T Professional). 
The PCR profile consisted of an initial denaturation step at 95°C for 5 minutes, 
followed by 32 cycles with denaturation steps at 95°C for 1 minute, primer 
annealing at 70.2°C for 45 seconds, and primer extension at 72°C for 1 minute. 
The PCR program was completed by final extension step at 72°C for 10 minutes to 
allow the complete extension of all PCR fragments. The PCR product exhibited a 
357 base-pair fragment and was checked on 2.5% agarose gel.   
PCR product (10 µl) was digested overnight with 10U RsaI (Fermentas), and the 
products were visualized by electrophoresis on 3% agarose containing 0.5 mg/mL 
ethidium bromide. The homozygous wild type allele (His139/His139) was 
identified by two bands (259 and 62 bp), whereas homozygous mutant allele 
(Arg139/Arg139) resulted in 3 bands (174, 121, 62 bp) after digestion and 
heterozygous individuals (His139/Arg139) produced all four bands. In other to 
verify our polymerase chain reaction-restriction fragment length polymorphism 
(PCR-RFLP) results, we repeated the PCR-RFLP stage twice for 20% of selected 
subjects. 
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Table 2: The DNA sample was amplified using the following primer pair 
Polymorphism Primer sequence 
EPHX1 (Tyr113His) 
Exon 3 
 
F: 5′-GAT CGA TAA GTT  CCG TTT CAC C-3′ 
R: 5′-ATC CTT AGT CTT  GAA GTG AGG AT-3′ 
EPHX1 (His139Arg) 
Exon 4 
 
F: 5′-GGG GTA CCA GAG CCT GAC CGT-3′ 
R: 5′-AAC ACC GGG CCC ACC CTT GGC-3′ 
 
3.6. STATISTICAL ANALYSIS 
Esophageal cancer risk was considered in relation to EPHX1 genotypes. 
Polymorphisms were categorized into Tyr113/Tyr113 (rapid), Tyr113/His113, 
His113/His113 (slow) for EPHX1 exon 3 and His139/His139 (slow), 
His139/Arg139 and Arg139/Arg139 (rapid) genotypes for exon 4, respectively. In 
addition we examined four genotype combinations representing imputed 
phenotypes according to Smith and Harrison (Smith and Harrison, 1997): rapid, 
exon 3 Tyr113/Tyr113 and exon 4 Arg139/Arg139 or His139/Arg139; 
intermediate (normal), exon 3 Tyr113/Tyr113 and exon 4 His139/His139 or exon 3 
Tyr113/His113 and exon 4 His139/Arg139; slow, exon3 Tyr113His113 and exon 4 
His139/His139 or Arg139/Arg139; very slow, exon 3 His113/His113 and exon 4 
His139/His139 or His139/Arg139 or Arg139/Arg139 (Table 3). 
Numbers and percentages by case status were calculated and presented for 
categorical variables. Conditional logistic regression models were used to compute 
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unadjusted and adjusted odds ratios (ORs) to estimate relative risk (RR), 95% 
confidence intervals (95% CIs). Conditional logistic regression models were 
adjusted for potential cofounders of age, sex, residence, smoking family history, 
education, religion. When one of these confounders was the variable of interest, the 
adjustment was made for the other possible confounders.  Fruit and vegetable 
intake data (grams per day) were transformed to logarithmic values following 
addition of 0.1 to the original values. All statistical analysis was done using 
STATA software, version 12 (Stata Corp., College Station, TX, USA). Two-sided 
P-value <0.05 were considered as statistically significant.   
 
Table 3: Predicted mEH enzyme activity based on classification of Smith and 
Harrison 
Exon 4 
(His139Arg) 
polymorphism 
Exon 3 (Tyr113His) polymorphism 
Genotypes Tyr/Tyr Tyr/His His/His 
His/His Intermediate Low Very low 
His/Arg Rapid Intermediate Very low 
Arg/Arg Rapid Low Very low 
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4.1 ANALYSIS OF EPHX1 EXON 3 AND EXON 4 POLYMORPHISM  
Analysis of EPHX1 exon 3 and exon 4 was conducted using PCR-RFLP method. 
The amplicons were analyzed on 2.5% agarose gel (Figure 4 and 5) and were then 
subjected to RFLP analysis. The restriction enzyme EcoRV and RsaI was used to 
distinguish the EPHX1 exon 3 and exon 4 polymorphism, respectively. In EPHX1 
exon 3 polymorphism, the wild-type (T/T) genotype (i.e., Tyr113/Tyr113) has RsaI 
restriction site and is represented by two bands (140 bp and 22 bp), the 
polymorphic (C/C) genotype (i.e., His113/His113) is represented by a single 
fragment (162 bp) and heterozygous (Tyr113/His113) is represented by all three 
bands (162 bp, 140 bp, and 22 bp). The digested products were analyzed by 3% 
agarose gel but 22 bp fragment was not resolved due to its small size (Figure 6). In 
EPHX1 exon 4 polymorphism, the wild type (A/A) genotype (His139/His139) was 
identified by two bands (295 bp and 62 bp), whereas the polymorphic (G/G) 
genotype (Arg139/Arg139) resulted in three bands after digestion (174 bp, 121 bp, 
62 bp) and heterozygous (His113/Arg139) produced all four bands (295 bp, 174 
bp, 121 bp, and 62 bp) (Figure 7). 
4.1.1 Demographic characteristics of EC cases and matched controls 
Table 4 shows the distribution of demographic characteristics of EC cases and 
matched controls. The mean ages of EC cases and controls were 62.11±11.34 
years and 61.27±11.44 years, respectively. About 58% of cases were males. 
Majority of the EC cases were Muslims (99.57%) and resided in the rural areas 
(97.20%). EC was more common among subjects with no formal education 
(88.09%). Daily fruit and vegetable intake was higher in controls (median grams 
per day 3.12±1.23) than EC cases (median grams per day 1.8±1.20). Smoking in 
various forms (Hookah, Cigarette, Bedi) was more common in cases (66.81%) 
than controls (51.91%). Distribution pattern of family history showed significant 
difference between EC cases and controls, cases (37.45%) tended to have reported 
first degree family history than controls (8.09%). 
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         Figure 4: 2.5% agarose gel demonstrating PCR of genomic DNA                   
         samples for detection of EPHXI exon 3 gene fragment. 
         Lane 1-7 representing 162 bp EPHXI exon 3 gene fragment. 
                 
 
        Figure 5: 2.5% agarose gel demonstrating PCR of genomic DNA                   
        samples for detection of EPHXI exon 4 gene fragment. 
               Lane 1, 2, 3, 4, 6, 7, 8 representing 357 bp EPHXI exon 4 gene fragment. 
        Lane 5 100 bp ladder. 
LANE      1           2           3           4           5           6           7           8 
LANE      1           2            3            4            5           6           7            8 
162 bp 
357 bp 
100 bp marker 
Results 
 
Chapter 4 Page 31 
 
 
 
 
 
Figure 6: 3% agarose gel demonstrating RFLP genotyping of EPHX1 exon 3 
(Tyr113His). 
Lane 3, 5 represents EPHX1 exon 3 homozygous wild (T/T) genotype (140 bp and     
22 bp). 
Lane 1, 6 represents EPHX1 exon 3 homozygous mutant (C/C) genotype (162 bp).  
Lane 2, 7 represents EPHX1 exon 3 heterozygous (T/C) genotype (162 bp, 140 bp, and 
 22 bp).  
Lane 4 represents 100 bp marker.  
 
 
 
  
LANE       1                 2                 3                4                  5                 6                  7              
162 bp 
140 bp 
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Figure 7: 3% agarose gel demonstrating RFLP genotyping of EPHX1 exon 4 
(His139Arg). 
Lane 1, 5, 7 represents EPHX1 exon 4 homozygous wild (A/A) genotype (295 bp 
and 62 bp). 
Lane 3 represents EPHX1 exon 4 homozygous mutant (G/G) genotype (174 bp, 
121 bp, and 62 bp).  
Lane 2, 6 represents EPHX1 exon 4 heterozygous (A/G) genotype (295 bp, 174 
bp, 121 bp, and 62 bp).  
Lane 4 represents 50 bp marker.  
Lane 8 represents PCR product (357bp) 
 
  
LANE        1             2               3              4             5              6              7             8 
295 bp 
174 bp 
121 bp 
357bp 
62bp 
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* Smoking in any form like Hookah, Cigarette, Bedi.                                                                   
P < 0.05 is considered statistically significant.                                      
 
Table 4: Demographic characteristics of EC cases and matched controls 
 
Characteristics 
 
 
 
Cases 
n (%) 
 
Control 
n (%) 
 
P value 
Total  235 (100) 235 (100)  
Age                   
(Years mean ± S.D) 
 62.11±11.34 61.27±11.44  
Gender 
 
     Male 138 (58.72) 138 (58.72)  
     Female 97 (41.28) 97 (41.28)  
Religion 
 
     Muslim 234(99.57) 233 (99.15)  
     Sikh 1(.43) 2 (0.85)  
Place of residence 
 
     Rural 228 (97.20) 228 (97.20)  
     Urban 7 (2.98) 7 (2.98)  
Education 
 
     No formal school 207 (88.09) 147 (62.55)  
     1 – 4 grade 12 (5.11) 41 (17.45)  
     5 – 8 grade 10 (4.26) 15 (6.38)  
     High school 5 (2.13) 18 (7.66)  
     College or above 1 (0.43) 14 (5.96) 0.001 
Fruit vegetables 
Median grams per day  
(interquartile range) 
 1.81±1.20 3.12±1.23 0.001 
Smoking
* 
     Never 78 (33.19) 113 (48.09)  
     Ever 157 (66.81) 122 (51.91) 0.001 
 
Income (INR) 
 
 
     < 5000 188 (80) 159 (67.65)  
     >5000 47 (20) 76 (32.34) 0.003 
Family history 
     No 147 (62.55) 216 (91.91)  
     Yes 88 (37.45) 19 (8.09) 0.001 
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4.1.2 Allelic and genotypic frequency of EPHX1 exon 3 and exon 4 
Table 5 shows the allelic frequency of EPHX1 exon 3 and exon 4 in EC cases and 
controls. The allelic distribution of EPHX1 exon 3 was significantly different 
between EC cases and controls (P = 0.001). Majority of the controls (70%) had 
wild type (T) allele (Figure 8). The presence of mutant allele (C) conferred the 
increased risk of EC (OR = 1.58; 95% CI 1.20 – 2.07). However, there was no 
statistic difference in allelic distribution of EPHX1 exon 4 between ESCC cases 
and controls (P = 0.933) (Figure 9).  
Table 6 shows the ORs (95% CIs) for the association between microsomal epoxide 
hydrolase (EPHX1) exon 3 and exon 4 genotypes and EC risk. The exon 3 
Tyr113/Tyr113 (wild genotype) was most prevalent in controls (53.19%) whereas 
the His113/His113 (mutant genotype) was higher in ESCC cases (Figure 10). The 
homozygous His113/His113 genotype was associated with the increased risk of EC 
in both unadjusted (OR = 2.19; 95% CI 1.32 – 3.62) and adjusted (OR = 3.25; 95% 
CI 1.68 – 6.29) logistic regression models. The homozygous Arg139/Arg139 
(mutant) variant of EPHX1 exon 4 was rare in both cases 1.70% (4/235) and 
controls 3.40% (8/235) (Figure 11). No relationship was found between EPHX1 
exon 4 polymorphism and ESCC risk, the unadjusted and adjusted odds ratio was 
0.51; 95% CI 0.51-1.70, and 0.51; 95% CI 0.09-2.76), respectively.  
ns = Number of Alleles.                                                                                                                         
P < 0.05 is considered statistically significant.                                  
Table 5: Illustrating frequency of EPHX1 exon 3 and exon 4 alleles in EC patients and 
controls 
Polymorphism Allele Cases                         
n
s
 (%) 
Controls                         
n
s
 (%) 
OR (95% CI) P value 
Total 470 (100) 470 (100)   
EPHX1 exon 3    
(Tyr113His) 
T 280 (59.57) 329 (70.0) 1 - 
C 190 (40.42) 141 (30.0) 1.58 (1.20-2.07) 0.001 
EPHX1 exon 4   
(His139Arg) 
A 382 (81.27) 384 (81.70) 1 - 
G 88 (18.72) 86 (18.29) 1.02 (0.74-1.42) 0.933 
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Figure 8 Histogram showing the distribution of EPHX1 exon 3 alleles in cases and             
controls 
 
Figure 9 Histogram showing the distribution of EPHX1 exon 4 alleles in cases and             
controls. 
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Table 6: Odds ratio and 95% CIs for EC risk by EPHX1 exon 3 and exon 4 genotypes 
Polymorphism 
Genotype Cases           
n (%) 
Controls           
n (%) 
Unadjusted OR 
(95% CI) 
Adjusted
*
     
OR (95% CI) 
Total 235 (100) 235 (100)   
EPHX1 exon 3    
(Tyr113His) 
Tyr113/Tyr113 102 (43.40) 125 (53.19) 1 1 
Tyr113/His113 76 (32.34) 79 (33.62) 1.21 (0.79-1.86) 1.47 (0.84-2.58) 
His113/His113 57 (24.26) 31 (13.19) 2.19 (1.32-3.62) 3.25 (1.68-6.29) 
EPHX1 exon 4    
(His139Arg) 
His139/His139 151 (64.26) 157 (66.81) 1 1 
His139/Arg139 80 (34.04) 70 (29.79) 1.17 (0.80-1.69) 1.53 (0.94-2.50) 
Arg139/Arg139 4 (1.70) 8 (3.40) 0.51 (0.15-1.70) 0.51 (0.09-2.76) 
n = Number of Individuals.                                                                                                                              
* Conditional logistic regression adjusted for age, sex, residence, smoking, family history,    
education, religion.                                                                                                                                               
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Figure 10 Histogram showing the distribution of EPHX1 exon 3 genotypes in cases 
and controls. 
 
Figure 11 Histogram showing the distribution of EPHX1 exon 4 genotypes in cases 
and controls.   
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4.1.3 Association between EPHX1 exon 3 and exon 4 combined genotypes and 
EC risk 
We also have investigated whether a combination of the microsomal epoxide 
hydrolase (EPHX1) exon 3 and exon 4 genotypes was associated with the EC risk. 
Table 7 shows the ORs (95% CIs) for the association between exon 3 and exon 4 
combined genotypes and EC risk. Our results showed that the homozygous wild 
genotype in both EPHX1 exon 3 and exon 4 (Tyr113/Tyr113 and His 139/His139) 
was most common in the controls (80/235; 34.04%). This genotypic combination 
depicting intermediate activity was associated with decreased risk of ESCC as 
compared to all other combinations. The frequency of combined His113/His113 
and His139/His139 genotype was higher in ESCC cases (47/235; 20.00%) than 
controls. The individuals carrying exon 3 homozygous mutant genotype and exon 
4 homozygous wild genotype had increased risk of ESCC (unadjusted OR = 2.63; 
95% CI 1.44 – 4.79 and adjusted OR = 3.93; 95% CI 1.76 – 8.78).  
4.1.4 Risk of EC associated with predicted mEH activity  
Pursuant to Smith and Harrison (Smith and Harrison, 1997), Table 8 shows the 
ORs (95% CIs) for the association between the predicted mEH activity and EC 
risk. Our results reported a significant difference in predicted mEH activity 
frequencies between EC cases and controls. Genotypic combinations 
(Tyr113/Tyr113 and His139/His139 or Tyr113/His113 and His139/Arg139) with 
predicted intermediate activity showed lowest ESCC risk. A significant increased 
risk of ESCC was found with predicted very slow mEH activity (unadjusted OR = 
1.77; 95% CI 1.15 – 2.72 and adjusted OR = 2.80; 95% 1.56 – 5.00).  
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Table 7: Odds ratio and 95% CIs for EC risk by EPHX1 exon 3 and exon 4 combined 
genotypes 
Genotype Cases                 
n (%) 
Controls             
n (%) 
Unadjusted   
OR (95% CI) 
Adjusted       
OR (95% CI) 
Total 235 (100) 235 (100)   
Combined EPHX1 Exon 3 & Exon 4 Genotypes 
Tyr113/Tyr113 & 
His139/His139 
56 (23.83) 80 (34.04) 1 1 
Tyr113/Tyr113 &             
His 139/Arg139 
44 (18.72) 38 (16.17) 1.59 (0.91-2.79) 2.06 (0.95-4.45) 
Tyr113/Tyr113 & 
Arg139/Arg139 
2 (0.85) 7 (2.98) 0.41 (0.08-2.05) 0.94 (0.11-7.71) 
Tyr113/His113 & 
His139/His139 
48 (20.43) 52 (22.13) 1.41 (0.80-2.48) 1.76 (0.86-3.62) 
Tyr113/His113 &             
His 139/Arg139 
26 (11.06) 26 (11.06) 1.46 (0.76-2.78) 2.58 (1.08-6.12) 
Tyr113/His113 & 
Arg139/Arg139 
2 (0.85) 1 (0.43) 3.5 (0.29-41.91) 0.51 (.02-9.72) 
His113/His113 & 
His139/His139 
47 (20.00) 25 (10.64) 2.6 (1.44-4.79) 3.93 (1.76-8.78) 
His113/His113 &       
His 139/Arg139 
10 (4.26) 6 (2.55) 2.25 (0.78-6.48) 5.60 (1.37-22.86) 
His113/His113 & 
Arg139/Arg139 
0 (0) 0 (0) - - 
n = Number of Individuals.                                                                                                       
* Conditional logistic regression adjusted for age, sex, residence, smoking, family history, 
education, religion.                                                                                                                  
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Table 8: Risk of EC associated with predicted mEH activity 
Genotype Cases                 
n (%) 
Controls             
n (%) 
Unadjusted   
OR (95% CI) 
Adjusted       
OR (95% CI) 
Total 235 (100) 235 (100)   
Predicted mEH activity
#
 
Rapid 0 (0) 0 (0) - - 
Intermediate 56 (23.83) 80 (34.04) 1 1 
Slow 48 (20.43) 52 (22.13) 1.39 (0.79-2.42) 1.84 (0.91-3.71) 
Very slow 131 (55.74) 103 (43.83) 1.77 (1.15-2.72) 2.80 (1.56-5.00) 
P for trend   0.008 <0.0001 
n = Number of Individuals.                                                                                                       
*Conditional logistic regression adjusted for age, sex, residence, smoking, family history, 
education, religion.                                                                                                                 
P < 0.05 is considered statistically significant.                                                                         
# 
Imputed phenotypes, as classified by Smith and Harrison. 
 
4.1.5 Analysis of EPHX1 exon 3 genotypes and mEH activity in EC cases and 
controls stratified by smoking status  
EPHX1 exon 3 genotypes and predicted mEH activity were considered in 
combination with smoking. Both unadjusted and adjusted ORs were calculated. 
Table 9 presents risk of EC for the combined effect of EPHX1 exon 3 genotypes 
and smoking status. Smokers with EPHX1 exon 3 homozygous mutant genotype 
(His113/His113) had higher ESCC risk (unadjusted OR = 2.48; 95% CI 1.02 – 
6.01 and adjusted OR = 3.5; 95% 1.15 – 11.00). However, there was no association 
between smoking and various predicted mEH activities. In case of non-smokers no 
association was found between EPHX1 exon 3 genotypes and ESCC risk 
(unadjusted OR = 3.5; 95% CI 1.15 – 11.00, and adjusted OR = 6.65; 95% 0.98 – 
44.84). For non-smokers the ESCC risk associated with predicted mEH activity 
could not be analyzed due to low sample size. 
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n = Number of Individuals.                                                                                                                    
* Conditional logistic regression adjusted for age, sex, residence, smoking, family history, 
education, religion.                                                                                                                   
#
 Predicted mEH activity as per Smith and Harrison.                                   
 
Table 9: EPHX1 exon 3 genotypes, predicted mEH activity and Smoking: unadjusted and 
adjusted ORs (95% CI) for EC cases and controls 
Genotype 
Cases                 
n (%) 
Controls             
n (%) 
Unadjusted    OR 
(95% CI) 
Adjusted       OR 
(95% CI) 
SMOKERS 
Total 157 (100) 122 (100)   
EPHX1 exon 3 genotypes 
Tyr113/Ty113 72 (45.86) 66 (54.10) 1 1 
Tyr113/His113 48 (30.57) 40 (32.79) 0.51 (0.22-1.15) 0.42 (0.16-1.11) 
His113/His113 37 (23.57) 16 (13.11) 2.48 (1.02-6.01) 3.5 (1.15-11.00) 
Predicted mEH activity
#
 
Rapid 0 (0) 0 (0) - - 
Intermediate 41 (26.11) 45 (36.89) 1 1 
Slow 30 (19.11) 25 (20.49) 0.80 (0.31-2.08) 0.72 (0.23-2.19) 
Very slow 86 (54.78) 52 (42.62) 1.39 (0.69-2.80) 2.29 (0.95-5.53) 
NON-SMOKERS 
Total 78(100) 113 (100)   
EPHX1 exon 3 genotypes 
Tyr113/Ty113 30 (38.46) 59 (52.21) 1 1 
Tyr113/His113 28 (35.90) 39 (34.51) 2.5 (0.68-9.43) 2.5 (0.14-44.05) 
His113/His113 20 (25.64) 15 (13.27) 3.5 (1.15-11.00) 6.65 (0.98-44.84) 
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In this hospital based case-control study, we evaluated the influence of EPHX1 
genetic variations on EC susceptibility and the relationship of such polymorphisms 
with potential risk factors of EC. Our results obtained by analyzing 235 EC cases 
and matched 235 controls demonstrate that the mean age of EC cases 
(62.11 11.34) was comparable to that of controls (61.27      ) and majority of 
the EC cases (51.7%) belonged to upper middle age group (range 60-70 years) 
(Table 4) which is in accordance with the studies that reported peak incidence 
between 60 and 70 years of age (Enzinger and Mayer, 2003). All the cases had 
ESCC subtype of EC which is in agreement with the earlier studies from the valley 
(Dar et al., 2012; Malik et al., 2011). Majority of our cases were males (58%), 
representing a male to female (138/97) ratio of 1.42:1. However, our data can not 
represent the actual incidence of disease in the region as it requires the 
maintenance of proper cancer registries which is not available in the region. All 
study subjects were locals with majority of ESCC cases from rural areas (97%), 
showing uneven distribution of incidence of ESCC in Kashmir. The observed 
uneven distribution could be in part due to the role of some environmental 
exposures, poor socioeconomic status, and dietary habits of the local population. 
Most of the rural inhabitants in Kashmir are engaged in agricultural activities, have 
frequent contact with animals. Such activities expose them to pesticides, 
fungicides, various animal viruses and specific microbes that may account for their 
high cancer risk than urban residents (Freeman et al., 2011; Koutros et al., 2010; 
Koutros et al., 2009; Landgren et al., 2009). 
EC is considered as the disease of poor and the socially disadvantaged. We found 
an inverse relation between various indicators of socio-economic status (SES) and 
the EC. Majority of the ESCC cases (80%) had a monthly income of less than 5000 
INR and most of the patients (88.09%) were without formal education. Fresh fruits 
and vegetables intake was more in controls (3.12 1.23) than cases (1.81 1.20) 
(Table 4). Our results are in agreement with several epidemiological studies 
(Brown et al., 1994; Cook-Mozaffari et al., 1979; Tran et al., 2005; Wei et al., 
2005; Weiderpass and Pukkala, 2006). The poor SES is not the biological cause of 
cancer but its influence may enhance the risk through behaviour, lifestyle, 
environmental exposures, and diet. Low SES may also be a measure of access to 
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the basic resources required to achieve and sustain a good health as well as life 
style with least risk (Shavers, 2007).  
Among the various risk factors of ESCC, the most important include tobacco 
smoking and alcohol drinking (Boffetta and Garfinkel, 1990; Brown et al., 1994; 
Carstensen et al., 1987; Doll et al., 1994; Freedman et al., 2007a; Ishikawa et al., 
2006; McLaughlin et al., 1995). We have earlier reported association of tobacco 
use in form of hookah smoking, nass chewing and ESCC risk in Kashmir (Dar et 
al., 2012). In the present group of subjects also majority of cases (66.81%) were 
tobacco smokers using it in form of Hookah, Cigarette, Biddi (Table 4). The 
tobacco use and risk of ESCC has been associated with toxic components such as 
nicotine, nitric oxide, carbon monoxide, PAH’s, and nitrosoamines present in 
tobacco smoke (Eissenberg and Shihadeh, 2009; Ghasemi et al., 2010; Jacob et al., 
2011; Monzer et al., 2008). Many of them are genotoxic, forming DNA adducts 
and their association with ESCC has been confirmed by several studies (Mirvish, 
1995; Poirier, 1997; Pratt et al., 2011). None of the subject in our study was an 
alcohol drinker, which is different from other parts of the world were incidence of 
ESCC is high. This difference could probably be due to their religious obligation. 
Several studies have reported positive association between family history and EC 
risk (Akbari et al., 2006; Hu et al., 2003; Ji and Hemminki, 2006). Likewise, in 
this study a good number of ESCC cases (37.45%) had positive family history of 
the same or different type of the cancer (Table 4). This important observation can 
help us to understand the role of shared susceptibility in esophageal 
carcinogenesis. It can be because of same risk factors as their ancestors were 
exposed to or some genetic vulnerability present in certain families which are 
inherited to their progenies. Therefore studying the genetic predisposition seems 
relevant in Kashmiri EC patients. 
In order to evaluate the genetic susceptibility we assessed the role of well 
characterized risk modifying genotypes of EPHX1 with EC risk. The allelic 
frequency of EPHX1 exon 3 (Tyr113His) was significantly different between 
ESCC cases and controls (P = 0.001). The frequency of wild allele (T) was higher 
among study subjects whereas mutant allele (C) was most common in EC patients 
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(40.42%). The presence of C allele (mutant) conferred the increased risk of ESCC 
(OR = 1.58; 95% CI 1.20 – 2.07). This T to C transition results in the decreased 
enzymatic activity and has been related to increased cancer risk by several studies 
(Erkisi et al., 2010; Harrison et al., 1999; Jain et al., 2008; Ulrich et al., 2001) 
which seems to be the main reason of the risk liked to this transition. However, no 
such difference in allelic distribution was seen in EPHX1 exon 4 (His139Arg) 
between ESCC cases and controls (P = 0.933) (Table 5).  
Our results show a significantly increased ESCC risk associated with EPHX1 exon 
3 His113/His113 homozygosity (OR = 3.25; 95% CI 1.68 – 6.29). The findings are 
in agreement with various reported studies (Erkisi et al., 2010; Harrison et al., 
1999; Jain et al., 2008; Ulrich et al., 2001). However, unlike our study, some 
studies have reported no association of the mutant variant (His113/His113) of exon 
3 with ESCC (Mitrou et al., 2007; Zhang et al., 2003). There is clear evidence 
from several studies that the presence of EPHX1 exon 3 His113/His113 genotype 
does confer lower mEH enzyme activity (Harrison et al., 1999; Hassett et al., 
1994). It is suggested amino acid substitution may result in the altered stability of 
mEH protein and hence altered enzymatic activity (Hassett et al., 1994; Raaka et 
al., 1998). Lower enzyme activity of mEH may result in the accumulation of 
reactive genotoxic-epoxide intermediates which are otherwise substrates for mEH, 
thus resulting in increased exposure of body to potential carcinogens and hence 
elevated risk to ESCC. We found no correlation between EPHX1 exon 4 
polymorphism and ESCC risk (OR = 0.51; 95% CI 0.09-2.76) and our results are 
supported by the previous studies that reported no association between exon 4 
polymorphism and risk of colon and, lung cancer (Erkisi et al., 2010; Harrison et 
al., 1999; Mitrou et al., 2007; Ulrich et al., 2001) (Table 6). 
On analyzing combination of the exon 3 Tyr113His and exon 4 His139Arg 
genotypes (Table 7), we found the Tyr113/Tyr113 and His139/His139 genotype 
combination (with intermediate predicted activity) was the most common genotype 
in our controls (80/235; 34.04%) and was associated with decreased ESCC risk. 
Moreover, the frequency of combined His113/His113 and His139/His139 
genotype was significantly higher in ESCC cases 20.00% (47/235) than controls 
10.64% (25/235), the combination which is related to very slow enzymatic activity. 
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The ESCC risk was enhanced by about 4-fold (OR = 3.93; 95% CI 1.76 – 8.78) 
when the two non-synonymous variants His113/His113 and His139/His139 (both 
representing slow phenotype) were present in combination, suggesting the 
synergistic effect of the EPHX1 exon 3 and exon 4 polymorphism in increasing the 
risk of ESCC. 
We categorized combined genotypes of our subjects into four levels of predicted 
mEH activity (very slow, slow, intermediate, rapid) according to Smith and 
Harrison (Smith and Harrison, 1997) to study cumulative effect of predicted 
enzyme activity on ESCC risk. A combined genotypes for very slow predicted 
activity (His113/His113 and either His139/His139 or His139/Arg139 or 
Arg139/Arg139) was significantly found to be associated with an increased risk of 
ESCC (OR = 2.80; 95% CI 1.56 – 5.00) (Table 8). The association between 
EPHX1 slow enzymatic activity and increased risk of ESCC was consistent across 
different distributions whether it was risk of ESCC associated with EPHX1 exon 3 
His113/His113 genotype, combined EPHX1 exon 3 and exon 4 genotypes or with 
predicted mEH activity. Adjustments for confounders (e.g. sex, residence, 
smoking, family history, education, religion) did not substantively change the 
relationship observed between genotypes and risk for ESCC, although a slight 
increase in relative risk was observed suggesting the possible effect of some other 
confounders that we may not have taken into account. 
On limiting our analysis to EPHX1 exon 3 genotypes and predicted mEH activity 
in ever smokers (Table 9), the risk of ESCC enhanced with His113/His113 (slow 
allele) genotype (OR = 3.5; 95%CI 1.15-11.00). However, we observed no 
statistical significant risk for ESCC when smoking and predicted mEH activity was 
considered (OR = 2.29; 95% CI 0.95-5.53). It suggests that the presence of 
smoking did not alter the ESCC risk associated with very slow enzymatic activity. 
This discrepancy with our findings could be due to the fact that mEH has been 
implicated in both protection against and potentiation of the effects of certain 
carcinogens. While enzyme can detoxify many CYP derived epoxides, in particular 
benzo(a)pyrene present in the cigarette smoke is converted to reactive 
intermediate, benzo(a)pyrene-7,8,9,10-tetrahydro-7,8-diol-9,10-epoxide (BPDE) 
through cascade of biotransformations (involving CYP1A1, CYP3A4, GSTs) which 
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is no longer a substrate for mEH and consequently displays a highly genotoxic 
potential (Friedberg et al., 1994; Holder et al., 1974). Higher mEH activity leads to 
higher concentrations of BPDE, BPDE-serum albumin adducts, and DNA adducts 
in the body compared with very low activity of mEH (Pastorelli et al., 1998). 
Moreover, in order to better understand the role of Benzo(a)pyrene in the etiology 
of ESCC , it is important to consider polymorphisms in the constituent enzymes 
responsible for the metabolism of these compounds (EPHX1, CYP1A1, CYP3A4, 
GST’s) and how their interaction ultimately regulate the process of cellular 
detoxification. In our study, environmental and dietary exposures, such as 
environmental toxins like alkenes, benzene, and dietary epoxides, or reactive 
epoxide intermediates generated from dietary polycyclic aromatic hydrocarbons 
and nitrosoamines, which are detoxified by mEH may play a role in development 
of ESCC. This could explain why genotype combination His113/His113 and 
His139/His139 (very slow predicted activity) increases the risk of ESCC.  
In conclusion, our study indicated that polymorphism of EPHX1 gene might be a 
risk modifying factor for ESCC. The exon 3 polymorphic variant (His113/His113) 
related to slow enzymatic activity was positively associated with ESCC risk, and 
risk was further increased in combination of exon 4 His139/His139 variant 
(representing slow phenotype) and in presence of tobacco smoke. Moreover 
combined genotypes for “very slow predicted activity” was significantly found to 
be associated with ESCC risk, suggesting the detoxification role of this enzyme. 
However, larger epidemiological studies are warranted to substantiate our findings. 
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CHEMICALS AND OTHER MISCELLANEOUS ITEMS 
The details of chemicals and other miscellaneous items used in the study 
CHEMICALS/ENZYMES    SOURCE 
Chemicals      
Absolute ethanol     Bengal Chemicals &                   
       Pharmaceuticals Ltd. 
Ammonium Chloride     Qualgens 
Bromophenol Blue     Qualgens 
Chloroform      Thomas Bakers 
Ethedium Bromide     Srl 
Ethylene Diamine Tetra Acetate   Loba Chemie 
Glacial Acetic Acid     Srl 
Hydrochloric Acid     Qualgens 
Isoamyl Alcohol     Thomas Bakers 
Isopropanol      Thomas Bakers 
Low Melting Agarose     Srl 
8-Hydroxyquinoline     Cdh 
Phenol       Srl 
Potassium Bicarbonate    Qualgens 
Sodium Dodecyl Sulfate    Qualgens 
Sodium Acetate     Srl 
Sodium Chloride     Merck 
Sodium Hydroxide     Hemedia 
Sucrose      Srl 
Te Buffer      Srl 
Tris Base      Srl 
Tris Hcl      Himedia 
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Enzymes 
Taq Polymerase     Fermentas 
Proteinase K      SRL 
RsaI         Fermentas 
EcoRV       Fermentas 
REAGENTS 
Reagents for DNA extraction 
Saturated Phenol: 
0.2% β- mercaptoethanol 
8-hydroxy quinoline 
0.1 M Tris chloride buffer    800ml 
0.5 M Tris chloride buffer    1000ml 
Phenol       1000ml 
The mixture obtained by adding equal volume of 0.5M Tris- Cl buffer and melted 
phenol was stirred for 15 min on magnetic stirrer. Two phases were allowed to 
separate. Upper aqueous phase was removed and equal volume of 0.1 M Tris-
chloride buffer was added. The saturation with 0.1 M Tris-Cl buffer was repeated 
till phenol > 7.8 pH was obtained. A pinch of β-mercaptoethanol and 8-hydroxy 
quinoline was added. Phenol was stored at 4˚C in a dark bottle. 
Lysis buffer: 
1 M Tris      2.0ml 
0.5M EDTA      400µl 
10% SDS      30.0ml 
Final volume of the solution was made 100ml with sterile distilled water. 
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Lysis solution: 
1 M Ammonium Chloride    15.5ml 
1M Potassium bicarbonate    1.0ml 
0.5 M EDTA      200µl 
Final volume was made 100ml with sterile distilled water. 
Proteinase K: 
Proteinase K      10mg 
Proteinase k was dissolved in 1 ml of demonized water and stored at -20˚C in 1 ml 
aliquots. 
SE Solution: 
5 M Sodium chloride     3ml 
0.5 M EDTA      8ml 
Final volume was made 200ml with sterile distilled water. pH was adjusted to 8. 
SDS (10%): 
SDS       10g 
SDS was dissolved in 100 ml sterile distilled water. 
Chloroform Isoamyl alcohol (CIA): 
Chloroform      24.0ml 
Isoamylalcohol     1.0ml 
Chloroform: isoamylalcohol, in the ratio 24:1 was prepared by mixing 24 ml of 
Chloroform and 1 ml of isoamyl alcohol. The solution was stored at 4˚C in dark 
bottle. 
Sodium acetate (3M): 
Sodium acetate      40.83g 
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Sodium acetate was dissolved in 100ml sterile distilled water; pH of the solution 
was adjusted to 5.0 using acetic acid. 
DNA storage buffer: 
0.5 M EDTA      0.01 ml 
1 M Tris      0.5 ml 
Final volume was made 50 ml with sterile distilled water. 
Reagents for Agarose gel electrophoresis 
Agarose (3%):        
Agarose       3g 
Buffer       100ml 
EtBr       5.0µl 
Agarose was dissolved in a buffer and heated till a clear solution is formed. EtBr 
was then added to the solution. 
Bromophenol Blue: 
Bromophenol Blue     0.4g 
Sucrose      20.0g 
Bromophenol blue was dissolved in 100ml of distilled water. 
From the above stock solution 31.25ml was taken and sucrose was added. Final 
volume was made 50ml with distilled water. 
Ethidium Bromide: 
Ethidium bromide     10mg 
Ehidium Bromide was dissolved in 1ml of distilled water. The solution was stored 
in a dark bottle at 4˚C. 
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50X TAE (pH 8.0):  
Tris base      242g 
0.5M       100ml 
Glacial acetic acid     57.1ml 
Final volume was made 1000ml with distilled water. 
1X TAE (pH 8.0): 
50 X TAE      20ml 
Final volume was made 1000ml with distilled water. 
Reagents for PCR 
Stock: 
Deoxyribosenucleotidetriphosphate (dNTP): 10mM each dATP, dGTP, dCTP and 
dTTP. 
Taq polymerase (5U/µl) 
10X Taq buffer 
50mM MgCl2. 
Primers: 100mM in sterile deionised water    
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GLASS /PLASTIC WARE 
The details of Glass ware and Plastic ware used during the course of study. 
Glass/ Plastic item: 
Centrifuge tubes 
Micro-pipettes 
Glass pipettes 
Syringes 
EDTA-Vials 
Microfuge tubes 
Micro-tips 
Tip-boxes 
Storage racks 
Measuring cylinders 
Beakers 
Reagent bottles 
Test tube stands 
EQUIPMENTS 
The details of equipments used during the course of study. 
Equipment   
Deep freezer (-20˚C) 
Centrifuge 
Spectrophotometer 
Vortex mixer 
Hot plate 
Magnetic stirrer 
Source 
Nirmal Instruments 
Avanti
TM 
ELICO 
Remi 
SHIV 
SHIV 
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Thermal cycler 
Electrophoresis apparatus 
Power supply 
UV-Tran illuminator 
Incubator 
Autoclave 
Refrigerator 
pH meter 
Gel documentation unit 
                                             
Stabilizer                
Eppendrof, Biometra, T Professional 
Banglore Geni 
Genei 
Hoeser 
Techno 
Techno 
Godrej 
HANNA 
Alpha Innotech Corporation 
Philips 
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Questionnaire for Main Exposure 
In all instances, code 9, 99, etc. should be used for missing information 
 
1. Information on subject 
 
1.1. Subject code: ……………..   1.1a. Cancer Site: ……………………cm 
1.2. Date of interview: ……………………… 
1.2.1  Name of the Subject: ………………………………………………. 
1.2.2 Present address and Telephone number/s: ……………………………..... 
Province: ……………………District: ………….………… 
1.3 Gender: (1) Male    (2) Female  
1.4 Age (completed years): ………………………  
1.5 Ethnicity/Region:                      
(1) Kashmiri   (2) Gogri  (3) Pahadi 
(4) Ladakhi                                (5) Other 
1.6 Religion:                                
(1) Muslim     (2)  Hindu        (3) Sikh   
(4)  Christian 
(5) Buddhist        (6) Other: ………………………                                            
1.7 Marital status:                    
(1) Unmarried                   (2) Married  (3) Widow                                     
(4) Divorced / separated (5) Other: …………………… 
1.8 Education received:                                                 
(1) Nil   (2) Less than 5
th
 Std.       (3) 5
th
-8
th
 Std.  
(4) High school  (5) College / Graduation (6) Post graduation 
(7) Any other…………………………..                                                
 
2. Residential history 
 
2.1 List all places of residence in which you have lived for at least one year, 
starting with place of birth  
N 
From 
age 
To age 
Place of 
residence 
(1) City (2) 
Village  
Province  District City  Village 
House 
type 
1 |__||__| |__||__| |__|     |__| 
2 |__||__| |__||__| |__|     |__| 
3 |__||__| |__||__| |__|     |__| 
4 |__||__| |__||__| |__|     |__| 
Type of houses: 1 wooden; 2= wood and Brick; 3= Adobe made; 4= brick and Iron 
made; 5 = other (Specify ); 6= Don’t Know 
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3. Occupational history  
 
3.1 At what age did you start working?    |__||__| 
3.2 At what age did you stop working?         |__||__| 
 3.3 List all jobs in which you have been employed for at least one year, starting 
from the first job: 
 
N 
From 
age 
To 
age 
Job title, 
occupation 
Code  Hours/Day 
***Intensity 
of  activity 
(1,2,3,4) 
1 |__||__| |__||__| …………….. |__||__||__| |__||__| |__| 
2 |__||__| |__||__| …………….. |__||__||__| |__||__| |__| 
3 |__||__| |__||__| …………….. |__||__||__| |__||__| |__| 
*** Intensity of activity: 1= jobs that can be done while sitting; 2= jobs that 
require minimal effort such as those done standing, sitting or with slow walk, that 
do not require much physical effort (e.g., shop assistant, hairdresser, guard, etc.); 
3= jobs that require carrying light loads, continuous working, mainly indoor 
activities and that would occasionally increase the heart rate slightly and cause 
light perspiration (e.g., cleaner, nurse, electrician, etc.); 4= jobs that require 
carrying heavy loads, brisk walking, mainly outdoor activity, that increase heart 
rate substantially and cause heavy sweating (e.g., miner, bricklayer, construction 
worker, shoveling, etc.) 
  
4. Diet 
  
4.1 What is your main food at home?        
4.2Which type of fuel did you use 20 years ago?       
(1) Coal  (2) Wood (3) Gas (4) Kerosene  (5) Electricity                                        
4.3 What is source of your drinking water?    |__|  
(1) Well (2) Running water (3) Pipe water  (4) Other 
4.4 For how long you have been using Pipe water (yrs)                    |__||__| 
 
5. Tobacco consumption 
 
5.1 Have you ever smoked regularly?             
      (at least once a day for at least 6 months)   (1) Yes,  (2) No                                                  
5.2 If yes, list consumption: 
 
PRODUCT (1) Yes 
(2) No 
From 
age 
To age Quantity per day 
Workdays Weekends 
Cigarettes |__| |__||__| |__||__| |__||__| |__||__| 
Appendix 
Chapter 7 Page 79 
 
 
Bidi  |__| |__||__| |__||__|      |__||__| |__||__| 
Hookah |__| |__||__| |__||__| |__||__| |__||__| 
Cannabis |__| |__||__| |__||__| |__||__| |__||__| 
Other………… |__| |__||__| |__||__| |__||__| |__||__| 
 
5.2.1 Quit Smoking details 
(1)Yes   (2)No From 
age 
To age No. of 
YRS 
|__| |__||__| |__||__|  
|__| |__||__| |__||__|  
 
5.3 If no, list regular exposure to passive smoking (at least 1 hour/day): 
Place 
(1) Yes 
(2) No 
From 
age 
To Age Hours/day Days/week 
H 
O 
M 
E 
Father |__| |__||__| |__||__| |__||__| |__| 
Mother |__| |__||__| |__||__| |__||__| |__| 
Brother |__| |__||__| |__||__| |__||__| |__| 
Sister |__| |__||__| |__||__| |__||__| |__| 
Spouse |__| |__||__| |__||__| |__||__| |__| 
Workplace |__| |__||__| |__||__| |__||__| |__| 
Public 
settings 
|__| |__||__| |__||__| |__||__| |__| 
 
5.4 Have you ever used smokeless tobacco or Nass regularly?   |__| 
(at least once a day for at least 6 months) (1) Yes, (2) No 
Type (1)Yes 
(2) NO 
From age To age Number per 
day 
Duration of 
placement (min) 
Tobacco |__| |__||__| |__||__| |__||__||__| |__||__||__| 
Nass |__| |__||__| |__||__| |__||__||__| |__||__||__| 
Chutka |__| |__||__| |__||__| |__||__||__| |__||__||__| 
Others……... |__| |__||__| |__||__| |__||__||__| |__||__||__| 
 
5.5 Placing site of Nass/chutka in mouth  
        (1) Gingival Rim (2) Under tongue (3) others      |__|  
6. Alcohol consumption  
      6.1 Have you ever consumed alcoholic beverages regularly?     
(at least once a week for at least 6 months) (1) Yes, (2) No  
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8. Personal history of cancer  
 
7.1 Have you ever been diagnosed with a cancer? (1) Yes,   (2) No |__|  
7.2 If yes, at what age?       |__||__| 
7.3 At which site of origin.       |__||__| 
1=mouth or pharynx, 2=esophagus, 3=stomach, 4=colon or 
rectum,5=pancreas, 6=liver, 7=larynx, 8=lung, 9=skin, 10=breast, 
11=uterus, 12=prostate, 13=bladder, 14=leukemia and lymphoma, 
15=other, 16 unknown. 
 
8. Family history of cancer  
 
8.1 Do you have any first-degree relatives who ever had a diagnosis of cancer?  
(1) Yes, (2) No      |__| 
8.1.1 If yes, please list them all: 
(1) Father   (2) Mother  (3) Brothers 
(4) Sisters   (5) Stepbrothers (6) Stepsisters 
(7) Sons   (8) Daughters  (9) Grandparents 
(10) Spouse (11) Other blood relatives (cousins, uncles, 
aunt, nephews, nieces, etc.) 
Relative Age at diagnosis 
|__||__| |__||__| 
|__||__| |__||__| 
|__||__| |__||__| 
 
 
8.2 How many first-degree relatives have you had? 
(Excluding those who died within the first year of their life, but including all 
others) 
Brothers |__||__| 
Sisters |__||__| 
Sons  |__||__| 
Daughters  |__||__| 
 
9. Radiation 
 
9.1 How many X-rays have you taken in your lifetime?  |__||__||__|  
 
10. Socioeconomic status evaluations 
 
Monthly income --------------------------------------------------------- 
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Which of following facilities are available in your household? 
SNo Facility (1) Yes     
(2) No 
How long you 
have owned one 
(years) 
10.1 Personal 
automobile 
  
10.2 Personal 
Motorcycle 
  
10.3 Colour TV   
10.4 B&W TV   
10.5 Bath inside your 
house 
  
10.6 Vacuum cleaner   
10.7 Washing machine   
10.8 Refrigerator   
10.9 Computer   
10.10 Education of pt.   
 
10.11 For Women (enter 98 for men) 
10.12 How many pregnancies have you had                        |__||__| 
10.12.1 How many live children have you given birth to  |__||__| 
 
Semi-quantitative food frequency Questionnaire 
Department of Biochemistry University of Kashmir, Hazratbal Srinagar 
(J&K) India-190006  
 
Row 
No. 
Type of food              Frequency of consumption 
Daily Weekly Monthly Never 
A Bread, cereals, 
legume 
    
1 
 
Rice  Kashmiri       
Rice from out side 
valley 
    
2 Wheat (rooti)     
Row 
No. 
Type of food and 
average 
consumption 
Frequency of consumption 
 
Daily Weekly Monthly Never 
B Cooked Vegetables     
3   Onions     
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4 Potatoes     
5 Tomatoes                             
(1) fresh  
(2) sundried                      
   
    
6 Brinjal                                 
(1) fresh (2) 
sundried       
                                                 
                                                
    
    
7 Radish                                  
(1) fresh 
 (2) sundried                                                                            
 
    
    
8   Turnip                              
 (1) fresh 
(2)sundried                                               
   
    
9 Pumpkin                            
(1) fresh 
 (2)sundried                      
   
    
10 Mixed veg.                     
(1) fresh  
(2) sundried                             
    
    
D Spices      
11 Pickles (No)      
12 Chilli power      
13 Green chilli     
14 Red chilli     
G FRUIT     
15 One medium-sized 
bunch of grapes 
    
16 Banana (one small, 
64 g) 
    
17 Pear (one moderate 
size, 170 g) 
    
18 Cherry (10 
moderate sized, 70 
g) 
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19 Watermelon (one 
slice, 6*5*4 cm) 
    
20 Apple (one 
moderate size) 
Delecious 
    
21  Apple (one 
moderate size) other 
types  
    
22 Apricot (one 
moderate sized) 
    
23 Citrus fruit (one 
moderate sized) 
    
24 Fresh fruit juice (1 
cupful ) 
    
H FATS AND OILS     
25 Cream (1 tbsp, 7 g)     
26 Saturated vegetable 
fat (dalda) (1 tbsp, 
15 g) 
    
27 Butter (matchbox 
sized, 20 g) 
    
28 Other oils (1 tbsp)     
29 What is your main drink?      
(1) Salted-Tea  (2) Lipton tea   (3) Other 
Volume (1) 
1-2 cup or  
glass daiy (2) 
3-5 cup or 
glass daily 
(3) more 
than 5 cup 
or glass 
daily 
Temperature  
Hot (1) 
Warm(2) 
With 
(1) 
Without 
milk(2) 
With (1) 
or 
without 
(2) 
Baking 
Soda 
Do use 
Samawar (1) 
or Vacuum 
flask (2) 
What do you 
eat with Tea 
(1)  Paste of 
Rice (2) 
Paste of 
Maize (3) 
Chapati  (4) 
Tandoori 
Rotti     (5) 
Nothing    
30 Spices used amount 
             (1) Less  (2) Modetate   (3) Very Much  
Do you use WUR (if Yes) 
 (1) every day (2) weekly  (3) to some foods only (4)Never used  
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Before filling up the questionnaire, subjects are asked about the risks and benefits 
of participation. Also the subject Confidentiality and Autonomy is kept under 
consideration to the full extent. 
Registration 
After a short conversation with the patient, clinic details like name, age, sex, 
complete address, phone number, and referring clinic are entered. If the patient 
agrees to participate in the study, he is asked to sign the informed consent and 
register him as a participant and vice versa for the non participant. Then the lowest 
possible number is given to the registered subject. 
Certification 
I have been given a chance to read the information and all parts of this study have 
been discussed with me. I have had all of my questions answered, and I consent to 
being a study participant. 
Participant---------------------------------      Witness-------------------------------------- 
Date         ---------------------------------      Date      ------------------------------------- 
